Pramipexole, a dopamine D3/D2 receptor-preferring agonist, attenuates reserpine-induced fibromyalgia-like model in mice

Pharmacology of human dopamine D3 receptor expressed in a mammalian cell line: comparison with D2 receptor

European Journal of Pharmacology Molecular Pharmacology ◽

10.1016/0922-4106(92)90107-7 ◽

1992 ◽

Vol 225 (4) ◽

pp. 331-337 ◽

Cited By ~ 294

Author(s):

Pierre Sokoloff ◽

Marc Andrieux ◽

Roger Besançon ◽

Catherine Pilon ◽

Marie-Pascale Martres ◽

...

Keyword(s):

Cell Line ◽

Mammalian Cell ◽

D2 Receptor ◽

Dopamine D3 Receptor ◽

D3 Receptor ◽

Mammalian Cell Line ◽

S33138 [N-[4-[2-[(3aS,9bR)-8-Cyano-1,3a,4,9b-tetrahydro[1]-benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenylacetamide], a Preferential Dopamine D3 versus D2 Receptor Antagonist and Potential Antipsychotic Agent. II. A Neurochemical, Electrophysiological and Behavioral Characterization in Vivo

Journal of Pharmacology and Experimental Therapeutics ◽

10.1124/jpet.107.132563 ◽

2007 ◽

Vol 324 (2) ◽

pp. 600-611 ◽

Cited By ~ 31

Author(s):

Mark J. Millan ◽

Per Svenningsson ◽

Charles R. Ashby ◽

Michael Hill ◽

Martin Egeland ◽

...

Keyword(s):

Receptor Antagonist ◽

D2 Receptor ◽

Antipsychotic Agent ◽

Dopamine D3 ◽

Behavioral Characterization

Quinelorane, a dopamine D3/D2 receptor agonist, reduces prepulse inhibition of startle and ventral pallidal GABA efflux: Time course studies

Pharmacology Biochemistry and Behavior ◽

10.1016/j.pbb.2008.05.012 ◽

2008 ◽

Vol 90 (4) ◽

pp. 686-690 ◽

Cited By ~ 6

Author(s):

Y QU ◽

N SWERDLOW ◽

M WEBER ◽

D STOUFFER ◽

L PARSONS

Keyword(s):

Prepulse Inhibition ◽

Receptor Agonist ◽

Time Course ◽

D2 Receptor ◽

Dopamine D3 ◽

Efflux Time ◽

THE PUTATIVE DOPAMINE D3 RECEPTOR ANTAGONIST PNU 99194A POTENTIATES THE DISCRIMINATIVE STIMULUS INDUCED BYTHE DOPAMINE D3/D2 RECEPTOR AGONIST 7-OH-DPAT

Behavioural Pharmacology ◽

10.1097/00008877-199808000-00052 ◽

1998 ◽

Vol 9 (1) ◽

pp. S31

Author(s):

R. Depoortere ◽

G. h. Perrault ◽

D. J. Sanger

Keyword(s):

Receptor Antagonist ◽

Discriminative Stimulus ◽

Receptor Agonist ◽

D2 Receptor ◽

Dopamine D3 Receptor ◽

D3 Receptor ◽

Dopamine D3 ◽

The Dopamine D3/D2 Receptor Agonist 7-OH-DPAT Induces Cognitive Impairment in the Marmoset

Pharmacology Biochemistry and Behavior ◽

10.1016/s0091-3057(98)00230-5 ◽

1999 ◽

Vol 63 (2) ◽

pp. 201-211 ◽

Cited By ~ 46

Author(s):

A.G Smith ◽

J.C Neill ◽

B Costall

Keyword(s):

Cognitive Impairment ◽

Receptor Agonist ◽

D2 Receptor ◽

Dopamine D3 ◽

Distribution of Dopamine D3 Receptor Expressing Neurons in the Human Forebrain Comparison with D2 Receptor Expressing Neurons

Neuropsychopharmacology ◽

10.1016/s0893-133x(98)00066-9 ◽

1999 ◽

Vol 20 (1) ◽

pp. 60-80 ◽

Cited By ~ 297

Author(s):

E Gurevich

Keyword(s):

D2 Receptor ◽

Dopamine D3 Receptor ◽

D3 Receptor ◽

Behavioral sensitization to cocaine in rats: evidence for temporal differences in dopamine D3 and D2 receptor sensitivity

Psychopharmacology ◽

10.1007/s00213-010-2154-7 ◽

2011 ◽

Vol 215 (4) ◽

pp. 609-620 ◽

Cited By ~ 20

Author(s):

Gregory T. Collins ◽

Yen Nhu-Thi Truong ◽

Beth Levant ◽

Jianyong Chen ◽

Shaomeng Wang ◽

...

Keyword(s):

Behavioral Sensitization ◽

D2 Receptor ◽

Receptor Sensitivity ◽

Temporal Differences ◽

S33138 [N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1]-benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenylacetamide], A Preferential Dopamine D3 versus D2 Receptor Antagonist and Potential Antipsychotic Agent: I. Receptor-Binding Profile and Functional Actions at G-Protein-Coupled Receptors

Journal of Pharmacology and Experimental Therapeutics ◽

10.1124/jpet.107.126706 ◽

2007 ◽

Vol 324 (2) ◽

pp. 587-599 ◽

Cited By ~ 43

Author(s):

Mark J. Millan ◽

Clotilde Mannoury la Cour ◽

Francesca Novi ◽

Roberto Maggio ◽

Valérie Audinot ◽

...

Keyword(s):

Receptor Antagonist ◽

G Protein ◽

Receptor Binding ◽

D2 Receptor ◽

Antipsychotic Agent ◽

G Protein Coupled Receptors ◽

Binding Profile ◽

Dopamine D3 ◽

G Protein Coupled ◽

Functional Actions

Antidepressant effects of pramipexole, a dopamine D3/D2 receptor agonist, and 7-OH-DPAT, a dopamine D3 receptor agonist, in olfactory bulbectomized rats

European Journal of Pharmacology ◽

10.1016/j.ejphar.2009.06.029 ◽

2009 ◽

Vol 616 (1-3) ◽

pp. 134-140 ◽

Cited By ~ 42

Author(s):

Megan E. Breuer ◽

Lucianne Groenink ◽

Ronald S. Oosting ◽

Erich Buerger ◽

Michiel Korte ◽

...

Keyword(s):

Receptor Agonist ◽

D2 Receptor ◽

Dopamine D3 Receptor ◽

D3 Receptor ◽

Antidepressant Effects ◽

Dopamine D3 ◽

S33138 (N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1] benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenyl-acetamide), a Preferential Dopamine D3 versus D2 Receptor Antagonist and Potential Antipsychotic Agent: III. Actions in Models of Therapeutic Activity and Induction of Side Effects

Journal of Pharmacology and Experimental Therapeutics ◽

10.1124/jpet.107.134536 ◽

2007 ◽

Vol 324 (3) ◽

pp. 1212-1226 ◽

Cited By ~ 57

Author(s):

Mark J. Millan ◽

Florence Loiseau ◽

Anne Dekeyne ◽

Alain Gobert ◽

Gunnar Flik ◽

...

Keyword(s):

Side Effects ◽

Receptor Antagonist ◽

D2 Receptor ◽

Antipsychotic Agent ◽

Therapeutic Activity ◽